ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signaling - Schmidt, S., Schumacher, N., Schwarz, J., Tangermann, S., Kenner, L., Schlederer, M., Sibilia, M., Linder, M., Altendorf-Hofmann, A., Knösel, T., Gruber, E. S., Oberhuber, G., Bolik, J., Rehman, A., Sinha, A., Lokau, J., Arnold, P., Cabron, A.-S., Zunke, F., Becker-Pauly, C., Preaudet, A., Nguyen, P., Huynh, J., Afshar-Sterle, S., Chand, A. L., Westermann, J., Dempsey, P. J., Garbers, C., Schmidt-Arras, D., Rosenstiel, P., Putoczki, T., Ernst, M., Rose-John, S. (Rockefeller University Press, 2018)
6224118
Keywords: WW-YZ